玻璃体内地塞米松植入剂（Ozurdex®）的一种新的副作用。
A New Side Effect of Intravitreal Dexamethasone Implant (Ozurdex®).
作者信息
Eris Erdem, Erdogan Gurkan, Perente Irfan, Demir Gokhan, Kepez Yildiz Burcin, Aygit Ebru Demet
机构信息
Dr. Resat Belger Beyoglu Eye Training and Research Hospital, Istanbul, Turkey.
出版信息
Case Rep Ophthalmol Med. 2017;2017:6369085. doi: 10.1155/2017/6369085. Epub 2017 Oct 2.
Abstract
Dexamethasone implant, 0,7 mg (Ozurdex, Allergan, Inc., Irvine, CA, USA), is drug mostly used in the treatment of the diabetic macular edema and edema related to retinal vein occlusion. By reporting this case we aimed to report a new side effect of 0.7 mg intravitreal dexamethasone implant that has not been reported in the literature before.
摘要
地塞米松植入剂，0.7毫克（奥助得，爱力根公司，美国加利福尼亚州欧文市），是一种主要用于治疗糖尿病性黄斑水肿及视网膜静脉阻塞相关水肿的药物。通过报告该病例，我们旨在报道一种0.7毫克玻璃体内注射地塞米松植入剂的新副作用，此副作用此前尚未见文献报道。
Zotero 插件